Bioxyne / Breathe Life Sciences (BLS) Bioxyne Limited (ASX:BXN) is an Australian life sciences and health products business. In June 2023  Bioxyne acquired BLS in an all shares transaction becoming the parent company of Breathe Life Sciences (“BLS”) and DR Watson®.  The Group, which is headquartered in Sydney and has offices in London, Manchester, Prague, Brisbane, and Nagoya, … Continue reading Investors Information